Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.

Oncoimmunology · 2021 · PMC8204974 · PMID 34178429

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an unfavorable trendno p-value reported

HG subgroup analysis showed an unfavorable trend for patients with ≥5 KIR ligands, with no significant difference, probably due to the small sample size ( Figure 5b ).

also in 104 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.